Official store is canadasteroiddepot.is — beware of fake sites. We only sell from this domain!

Ships from within Canada | Discreet Packaging | No Customs

Pfizer Ngenla - 60mg/1.2mL [pGHD]

SKU 20125

$616.90

In stock — dispatches within 24h, tracked

Pfizer Ngenla 60mg/1.2mL long acting growth hormone formulation with pharmaceutical grade quality and precise delivery.

Pay with Interac e-Transfer or Crypto

Ships from within Canada; No Customs

Discreet plain packaging; always

24h dispatch; Tracked Delivery

Ngenla, manufactured by Pfizer, contains Somatrogon, a long acting recombinant human growth hormone analogue with a fundamentally different molecular structure from standard rHGH preparations like Genotropin. Somatrogon is engineered through the fusion of the native growth hormone sequence with three copies of a carboxy terminal peptide (CTP) derived from human chorionic gonadotropin’s beta subunit. A structural modification specifically designed to extend the compound’s plasma half-life from the daily administration requirement of standard rHGH to a once weekly dosing schedule.

The CTP fusion technology underlying Somatrogon’s extended half-life represents a meaningfully different approach to growth hormone axis research compared to every other compound in CSD’s range. Standard rHGH formulations like Genotropin require daily or near daily administration due to native somatropin’s short plasma half-life. GHRH analogues and GHRPs stimulate endogenous pulsatile GH secretion through receptor mediated pathways rather than delivering exogenous hormone directly. Somatrogon delivers the growth hormone molecule itself, like standard rHGH but with CTP fusion extending its circulating half-life sufficiently to support once weekly administration, producing a sustained growth hormone exposure profile that differs from both the pulsatile pattern of endogenous secretion and the daily peaks of standard rHGH administration.

Pfizer’s pharmaceutical manufacturing of Ngenla carries full regulatory approval for pediatric growth hormone deficiency, contributing clinical trial data examining the pharmacokinetic and pharmacodynamic differences between once weekly Somatrogon and daily rHGH administration. Comparative research area unique to long acting GH analogues. As with Pfizer’s Genotropin, authenticity verification is a relevant consideration given counterfeit risk in the pharmaceutical branded growth hormone category, and CSD verifies genuine Pfizer product through its sourcing process before stocking. Within CSD’s growth hormone research range, Ngenla’s CTP fused extended half-life profile positions it as a distinct research subject from standard rHGH, GHRH analogues, and GHRPs.

Pfizer Ngenla is stocked by Canada Steroid Depot following the same rigorous third party verification process applied to every product in our range, with additional authenticity verification specific to pharmaceutical branded products. CSD’s sourcing standards ensure genuine Pfizer product reaches researchers requiring verified pharmaceutical grade long acting growth hormone analogues. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Store at 2–8°C away from direct light. Do not freeze. Intended for research purposes only.

Commonly researched alongside standard rHGH and GHRH analogue compounds in comparative growth hormone axis activation pattern studies. Browse CSD’s full HGH and peptide range for complete sourcing.